Surgical Applications

Patient Identification

Which Patients Should be Considered for a Surgically-Implanted Impella® Heart Pump?

Significant hemodynamic deficit
Potential need to escalate support

Why escalate?

Unload the left ventricle
Increase end organ perfusion
Facilitate ambulation with axillary insertion of Impella 5.0® or Impella 5.5® with SmartAssist®

Impella 5.5 with SmartAssist for COVID-19 Patient

Cardiac Surgeon David D’Alessandro, MD, presents a case of 44-year-old woman with COVID-19 and myocarditis.

Learn More

Resources from the Education Library

Escalation Strategies that Increase Unloading

Cardiothoracic Surgeon Mark Anderson, MD, discusses how cardiac surgery may help move the data closer to ≥80% survival-to-discharge quality measure in the National Cardiogenic Shock Initiative (NCSI) Study.

Impressive Survival and Heart Recovery Rates with Impella 5.5 with SmartAssist

Cardiac Surgeon Danny Ramzy, MD, reports the first U.S. experience with Impella 5.5 with SmartAssist.

Discussion of Impella versus ECMO: The Right Choice for Patients

Michael Tong, MD, MBA, FRCSC, Edward Soltesz, MD, MPH, and Shinya Unai, MD, discuss considerations for when ECMO or Impella is the right choice for their patients.

Clinical Evidence

Learn more about key findings from RECOVER I and other ongoing clinical trials

NPS-1194